Zynex Deferred Long Term Liab vs Good Will Analysis

ZYXI Stock

USD 8.35 0.02 0.24%

Zynex financial indicator trend analysis is more than just analyzing Zynex Inc current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zynex Inc is a good investment. Please check the relationship between Zynex Deferred Long Term Liab and its Good Will accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Deferred Long Term Liab vs Good Will

Deferred Long Term Liab vs Good Will Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zynex Inc Deferred Long Term Liab account and Good Will. At this time, the significance of the direction appears to have weak relationship.

The correlation between Zynex's Deferred Long Term Liab and Good Will is 0.3. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Good Will in the same time period over historical financial statements of Zynex Inc, assuming nothing else is changed. The correlation between historical values of Zynex's Deferred Long Term Liab and Good Will is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Zynex Inc are associated (or correlated) with its Good Will. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Good Will has no effect on the direction of Deferred Long Term Liab i.e., Zynex's Deferred Long Term Liab and Good Will go up and down completely randomly.

Correlation Coefficient

0.3

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Good Will

An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.

Most indicators from Zynex's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zynex Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

As of now, Zynex's Enterprise Value is increasing as compared to previous years.

	2021	2022	2023	2024 (projected)
Interest Expense	95K	440K	1.1M	1.1M
Depreciation And Amortization	2.3M	3.1M	4.2M	4.4M

Interest Expense Depreciation And Amortization

Zynex fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Total Stockholder Equity	Retained Earnings	Common Stock Total Equity	Other Current Assets	Other Stockholder Equity	Total Current Assets	Common Stock	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Non Current Assets Total	Long Term Debt	Net Receivables	Non Current Liabilities Total	Inventory	Property Plant And Equipment Gross	Short Term Debt	Property Plant Equipment	Non Currrent Assets Other
Common Stock Shares Outstanding		0.32	0.38	0.17	-0.91	0.19	0.42	0.34	-0.91	0.22	0.14	0.43	0.48	0.33	0.3	-0.13	0.35	0.26	0.09	0.36	0.13	0.32	0.3	0.4	0.38	0.32
Total Assets	0.32		0.92	0.74	-0.11	0.84	0.7	0.99	-0.19	0.94	0.88	0.36	0.91	0.99	0.48	0.39	0.91	0.98	0.74	0.95	0.91	0.95	0.99	0.81	0.47	0.55
Total Stockholder Equity	0.38	0.92		0.7	-0.1	0.72	0.86	0.93	-0.14	0.73	0.63	0.45	0.84	0.92	0.67	0.02	0.73	0.86	0.48	0.9	0.67	0.89	0.9	0.73	0.56	0.65
Retained Earnings	0.17	0.74	0.7		-0.08	0.83	0.25	0.79	-0.16	0.69	0.69	0.18	0.52	0.69	0.41	0.25	0.74	0.63	0.74	0.68	0.7	0.78	0.72	0.36	0.03	0.34
Common Stock Total Equity	-0.91	-0.11	-0.1	-0.08		-0.09	-0.08	-0.14	0.99	-0.11	-0.07	-0.27	-0.31	-0.11	-0.08	-0.01	-0.28	-0.06	-0.07	-0.17	-0.05	-0.17	-0.11	-0.27	-0.12	-0.06
Other Current Assets	0.19	0.84	0.72	0.83	-0.09		0.37	0.88	-0.18	0.83	0.85	0.0	0.62	0.77	0.27	0.33	0.9	0.73	0.88	0.67	0.85	0.78	0.8	0.53	0.15	0.42
Other Stockholder Equity	0.42	0.7	0.86	0.25	-0.08	0.37		0.69	-0.08	0.47	0.33	0.49	0.74	0.74	0.65	-0.2	0.44	0.69	0.09	0.73	0.38	0.64	0.69	0.7	0.73	0.64
Total Current Assets	0.34	0.99	0.93	0.79	-0.14	0.88	0.69		-0.22	0.91	0.86	0.33	0.88	0.97	0.51	0.32	0.91	0.94	0.74	0.93	0.88	0.95	0.98	0.78	0.45	0.55
Common Stock	-0.91	-0.19	-0.14	-0.16	0.99	-0.18	-0.08	-0.22		-0.21	-0.18	-0.26	-0.37	-0.19	-0.07	-0.1	-0.37	-0.14	-0.19	-0.23	-0.15	-0.24	-0.19	-0.32	-0.12	-0.07
Total Liab	0.22	0.94	0.73	0.69	-0.11	0.83	0.47	0.91	-0.21		0.98	0.24	0.86	0.92	0.26	0.66	0.94	0.95	0.87	0.87	0.99	0.88	0.95	0.77	0.33	0.4
Short Long Term Debt Total	0.14	0.88	0.63	0.69	-0.07	0.85	0.33	0.86	-0.18	0.98		0.13	0.76	0.85	0.16	0.72	0.93	0.89	0.93	0.78	1.0	0.82	0.89	0.68	0.23	0.33
Other Current Liab	0.43	0.36	0.45	0.18	-0.27	0.0	0.49	0.33	-0.26	0.24	0.13		0.53	0.4	0.03	0.0	0.13	0.4	-0.04	0.51	0.16	0.37	0.36	0.35	0.49	0.09
Total Current Liabilities	0.48	0.91	0.84	0.52	-0.31	0.62	0.74	0.88	-0.37	0.86	0.76	0.53		0.93	0.41	0.42	0.81	0.92	0.52	0.96	0.78	0.92	0.92	0.95	0.55	0.46
Property Plant And Equipment Net	0.33	0.99	0.92	0.69	-0.11	0.77	0.74	0.97	-0.19	0.92	0.85	0.4	0.93		0.53	0.38	0.87	0.98	0.67	0.96	0.88	0.95	1.0	0.85	0.55	0.55
Current Deferred Revenue	0.3	0.48	0.67	0.41	-0.08	0.27	0.65	0.51	-0.07	0.26	0.16	0.03	0.41	0.53		-0.29	0.32	0.42	0.06	0.52	0.21	0.51	0.49	0.41	0.39	0.58
Net Debt	-0.13	0.39	0.02	0.25	-0.01	0.33	-0.2	0.32	-0.1	0.66	0.72	0.0	0.42	0.38	-0.29		0.56	0.5	0.65	0.39	0.69	0.4	0.43	0.4	-0.15	-0.14
Accounts Payable	0.35	0.91	0.73	0.74	-0.28	0.9	0.44	0.91	-0.37	0.94	0.93	0.13	0.81	0.87	0.32	0.56		0.87	0.86	0.83	0.93	0.88	0.9	0.73	0.17	0.42
Non Current Assets Total	0.26	0.98	0.86	0.63	-0.06	0.73	0.69	0.94	-0.14	0.95	0.89	0.4	0.92	0.98	0.42	0.5	0.87		0.7	0.95	0.91	0.91	0.98	0.82	0.48	0.53
Long Term Debt	0.09	0.74	0.48	0.74	-0.07	0.88	0.09	0.74	-0.19	0.87	0.93	-0.04	0.52	0.67	0.06	0.65	0.86	0.7		0.57	0.92	0.65	0.73	0.41	0.05	0.26
Net Receivables	0.36	0.95	0.9	0.68	-0.17	0.67	0.73	0.93	-0.23	0.87	0.78	0.51	0.96	0.96	0.52	0.39	0.83	0.95	0.57		0.81	0.97	0.95	0.86	0.45	0.49
Non Current Liabilities Total	0.13	0.91	0.67	0.7	-0.05	0.85	0.38	0.88	-0.15	0.99	1.0	0.16	0.78	0.88	0.21	0.69	0.93	0.91	0.92	0.81		0.84	0.91	0.69	0.26	0.36
Inventory	0.32	0.95	0.89	0.78	-0.17	0.78	0.64	0.95	-0.24	0.88	0.82	0.37	0.92	0.95	0.51	0.4	0.88	0.91	0.65	0.97	0.84		0.95	0.84	0.36	0.47
Property Plant And Equipment Gross	0.3	0.99	0.9	0.72	-0.11	0.8	0.69	0.98	-0.19	0.95	0.89	0.36	0.92	1.0	0.49	0.43	0.9	0.98	0.73	0.95	0.91	0.95		0.84	0.5	0.53
Short Term Debt	0.4	0.81	0.73	0.36	-0.27	0.53	0.7	0.78	-0.32	0.77	0.68	0.35	0.95	0.85	0.41	0.4	0.73	0.82	0.41	0.86	0.69	0.84	0.84		0.59	0.43
Property Plant Equipment	0.38	0.47	0.56	0.03	-0.12	0.15	0.73	0.45	-0.12	0.33	0.23	0.49	0.55	0.55	0.39	-0.15	0.17	0.48	0.05	0.45	0.26	0.36	0.5	0.59		0.39
Non Currrent Assets Other	0.32	0.55	0.65	0.34	-0.06	0.42	0.64	0.55	-0.07	0.4	0.33	0.09	0.46	0.55	0.58	-0.14	0.42	0.53	0.26	0.49	0.36	0.47	0.53	0.43	0.39

Click cells to compare fundamentals

Zynex Account Relationship Matchups

Zynex fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	37.4M	38.4M	43.1M	39.1M	36.1M	30.4M
Total Assets	28.3M	72.2M	133.3M	116.5M	136.9M	143.7M
Total Stockholder Equity	19.7M	56.9M	73.9M	66.4M	46.1M	48.4M
Retained Earnings	14.4M	23.4M	0.0	17.0M	26.8M	28.1M
Other Current Assets	315K	2.8M	1.4M	868K	3.3M	3.5M
Other Stockholder Equity	5.4M	33.4M	73.9M	49.3M	19.3M	10.8M
Total Current Assets	22.6M	63.0M	82.7M	69.6M	87.9M	92.2M
Liabilities And Stockholders Equity	28.3M	72.2M	133.3M	116.5M	136.9M	143.7M
Total Liab	8.6M	15.3M	59.3M	50.1M	90.8M	95.3M
Short Long Term Debt Total	4.7M	7.3M	35.1M	27.0M	76.2M	80.0M
Other Current Liab	1.8M	864K	4.5M	5.5M	1.6M	1.9M
Total Current Liabilities	5.2M	10.1M	22.9M	21.1M	18.5M	19.5M
Property Plant And Equipment Net	4.7M	7.9M	18.5M	15.0M	16.2M	17.0M
Net Debt	(9.4M)	(31.8M)	(7.5M)	6.8M	31.6M	33.2M
Accounts Payable	2.1M	4.7M	4.7M	5.6M	8.4M	8.9M
Non Current Assets Total	5.7M	9.2M	50.6M	46.9M	49.0M	51.5M
Net Receivables	5.8M	13.8M	28.6M	35.1M	26.8M	28.2M
Non Current Liabilities Total	3.4M	5.2M	36.5M	29.0M	72.2M	75.9M
Inventory	2.4M	8.6M	10.8M	13.5M	13.1M	13.8M
Property Plant And Equipment Gross	4.7M	7.9M	18.5M	15.0M	18.4M	19.3M
Short Term Debt	1.3M	4.3M	11.3M	7.9M	7.9M	8.2M
Property Plant Equipment	4.9M	1.9M	18.9M	2.2M	2.5M	3.0M
Non Currrent Assets Other	509K	668K	974K	861K	409K	429.5K
Cash	14.0M	39.2M	42.6M	20.1M	44.6M	46.8M
Other Assets	842K	913K	1.3M	2.2M	1.0	0.95
Cash And Short Term Investments	14.0M	39.2M	42.6M	20.1M	44.6M	46.8M
Net Tangible Assets	19.7M	56.9M	43.5M	36.9M	42.4M	44.5M
Retained Earnings Total Equity	4.9M	14.4M	23.4M	17.0M	19.6M	20.6M
Capital Surpluse	9.2M	37.2M	80.4M	82.4M	94.8M	99.5M
Capital Lease Obligations	4.7M	7.3M	19.2M	16.3M	18.6M	19.5M

Currently Active Assets on Macroaxis

ESRT	Empire State Realty
C	Citigroup
C	Citigroup
GOOG	Alphabet Inc Class C
DD	Dupont De Nemours

When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:

How To Invest In Zynex

Details

Is Zynex Stock a good investment?

Details

What is Zynex's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.30)

Earnings Share

0.14

Revenue Per Share

5.984

Quarterly Revenue Growth

0.001

Return On Assets

0.0399

The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Zynex Deferred Long Term Liab vs Good Will Analysis

Deferred Long Term Liab vs Good Will

Deferred Long Term Liab vs Good Will Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Good Will

Zynex fundamental ratios Correlations

Zynex Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Zynex fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Assets
Property Plant And Equipment Gross	+ 0.99	Total Assets
Common Stock	+ 0.99	Common Stock Total Equity

Common Stock	- 0.91	Common Stock Shares Outstanding
Common Stock Total Equity	- 0.91	Common Stock Shares Outstanding
Accounts Payable	- 0.37	Common Stock
Total Current Liabilities	- 0.37	Common Stock
Short Term Debt	- 0.32	Common Stock
Total Current Liabilities	- 0.31	Common Stock Total Equity